PillRx only · Tablet · Oral
Repaglinide
Repaglinide
7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US19 NDCs
7 active makers
7 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers7 labelers
Packages33
DEA / ScheduleNone
US acquisition costNADAC · per unit
Average across 15 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.086
Latest avg · Jun 17, 2026
-1%
Since Dec 17, 2025
7
Active US suppliers
42%
Top-2 supplier share*
Who makes it7 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Aurobindo Pharma Limited | unknown | 8 | SUPPLYING |
| Macleods Pharmaceuticals Limited | unknown | 6 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 6 | SUPPLYING |
| Rising Pharma Holdings, Inc. | unknown | 6 | SUPPLYING |
| Chartwell RX, LLC | unknown | 3 | SUPPLYING |
| NorthStar RxLLC | unknown | 3 | SUPPLYING |
| American Health Packaging | unknown | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.